Bank Of Montreal Immunity Bio, Inc. Put Options Transaction History

Bank Of Montreal

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$4.82 - $9.15 $1.21 Million - $2.3 Million	-251,400 Reduced 99.02%	2,500 $15,000
Q1 2024 May 13, 2024	BUY	$3.23 - $6.17 $17,765 - $33,935	5,500 Added 2.21%	253,900 $1.36 Million
Q4 2023 Feb 08, 2024	BUY	$1.25 - $5.21 $250,625 - $1.04 Million	200,500 Added 418.58%	248,400 $1.25 Million
Q3 2023 Nov 01, 2023	BUY	$1.29 - $3.1 $61,791 - $148,490	47,900 New	47,900 $80,000
Q1 2023 Jun 13, 2024	SELL	$1.35 - $4.78 $211,140 - $747,592	-156,400 Reduced 61.6%	97,500 $177,000
Q4 2022 Feb 01, 2023	BUY	$4.35 - $6.77 $1,305 - $2,030	300 Added 0.31%	97,500 $494,000
Q3 2022 Nov 10, 2022	BUY	$3.65 - $6.43 $354,780 - $624,996	97,200 New	97,200 $515,000

212

63.3M

1.44M

4.01M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $2.17B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.